lopinavir has been researched along with MODS in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R | 1 |
| Cheng, X; Guan, X; Jin, L; Liang, L; Liao, X; Liu, Y; Shi, Y; Song, L; Su, R; Wang, J; Xin, S; Xing, L; Xu, X; Yang, F; Yu, R; Yu, Y; Zhang, D; Zhou, W; Zhu, B | 1 |
2 other study(ies) available for lopinavir and MODS
| Article | Year |
|---|---|
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes | 2020 |
Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hospitalization; Humans; Indoles; Interferons; Length of Stay; Lopinavir; Male; Middle Aged; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2020 |